Clinical trial begins of plant based drug for Covid-19
On 5th June, 2020, the Drugs Controller General of India allowed Sun Pharmaceutical to conduct trial for the first phytopharmaceutical or plant based drug AQCH to treat covid-19 patients.
The trial has begun by Sun pharmaceutical in collaboration with ICGEB New Delhi and CSIR IIIM Jammu with support by CSIR and DBT.
Mumbai based Sun Pharma started the clinical trial for ACQH for Covid-19 after the plant based drug, which is being developed for dengue, showed broad antiviral effect in studies.
The Phase 1 clinical trials went very well and based on encouraging results it is being tried against Covid-19. Typically a clinical trial takes a long time, and the ACQH clinical trial will be done in three months or it might take some more time.
This is a multi-centric clinical trial so it will be held not only Delhi but several places in India will take patients for the trial.